Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer

H Wang, Z Lu, X Zhao - Journal of hematology & oncology, 2019 - Springer
Hepatocellular carcinoma (HCC, also called primary liver cancer) is one of the most fatal
cancers in the world. Due to the insidiousness of the onset of HCC and the lack of effective …

Extracellular vesicles as biomarkers in liver diseases: a clinician's point of view

S Thietart, PE Rautou - Journal of hepatology, 2020 - Elsevier
Extracellular vesicles are membrane-bound vesicles containing proteins, lipids, RNAs and
microRNAs. They can originate from both healthy and stressed cells, and provide a …

Utility of liquid biopsy analysis in detection of hepatocellular carcinoma, determination of prognosis, and disease monitoring: a systematic review

VL Chen, D Xu, MS Wicha, AS Lok… - Clinical Gastroenterology …, 2020 - Elsevier
Background & Aims Liquid biopsies, or blood samples, can be analyzed to detect circulating
tumor cells (CTCs), cell-free DNA (cfDNA), and extracellular vesicles, which might identify …

Exosomes and hepatocellular carcinoma: from bench to bedside

R Sasaki, T Kanda, O Yokosuka, N Kato… - International journal of …, 2019 - mdpi.com
As hepatocellular carcinoma (HCC) usually occurs in the background of cirrhosis, which is
an end-stage form of liver diseases, treatment options for advanced HCC are limited, due to …

Role of exosomes in immune microenvironment of hepatocellular carcinoma

X Chen, H Chi, X Zhao, R Pan, Y Wei… - Journal of …, 2022 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the most common primary liver cancer. Since most
patients with HCC are diagnosed at the intermediate or advanced stage and because HCC …

The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma

LTF de Lima, D Broszczak, X Zhang, K Bridle… - … et Biophysica Acta (BBA …, 2020 - Elsevier
Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide.
Despite advances in systemic therapies, patient survival remains low due to late diagnosis …

HCC biomarkers–state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice

S Schlosser, D Tümen, B Volz, K Neumeyer… - Frontiers in …, 2022 - frontiersin.org
Hepatocellular carcinoma (HCC) is one of the most common and deadly tumors worldwide.
Management of HCC depends on reliable biomarkers for screening, diagnosis, and …

Liquid biopsy in hepatocellular carcinoma: where are we now?

F Pelizzaro, R Cardin, B Penzo, E Pinto, A Vitale… - Cancers, 2021 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is one of the mostly lethal cancers, with a
prognosis which is still very poor. Novel reliable biomarkers, useful in early diagnosis and …

The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma

G Xu, WY Xu, Y Xiao, B Jin, SD Du, Y Mao… - Cancer Cell …, 2020 - Springer
Accumulating evidence has emerged revealing that noncoding RNAs (ncRNAs) play
essential roles in the occurrence and development of hepatocellular carcinoma (HCC) …

[HTML][HTML] Exosome in Hepatocellular Carcinoma: an update

W Chen, Y Mao, C Liu, H Wu, S Chen - Journal of cancer, 2021 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a common malignant tumor in the digestive tract with
limited therapeutic choices. Intercellular communication among cancer cells and their …